e2v Secures Contract Renewal Worth Over £ 40m

SEOUL, SOUTH KOREA--(Korea Newswire)--e2v(http://www.e2v.com/) technologies announces it has secured a multi-year contract renewal worth over £ 40m.

e2v will supply products from its RF Power division for incorporation within linear accelerators, a key sub-system for radiotherapy cancer treatment machines, to Elekta Ltd, Crawley, UK. The requirement is for both new equipment and the ongoing service and support of installed systems.

The contract is effective from 1st February 2013 and covers a period of 3 years and 3 months.

e2v's products generate and deliver the microwave power required from the linear accelerator within the radiotherapy cancer treatment system to produce the X-rays used in both the imaging and radiation treatment of tumours.

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. Elekta provides intelligent and resource-efficient technologies that improve, prolong and save patient lives.

Keith Attwood, CEO of e2v, said, “This contract with Elekta reinforces our position as a trusted partner for innovative solutions to this important marketplace.”

This is a news release distributed by Korea Newswire on behalf of this company.